OKYO Pharma (OKYO)

NASDAQ
Currency in USD
1.071
-0.009(-0.82%)
Real-time Data
OKYO Scorecard
Full Analysis
Suffers from weak gross profit margins
Earnings results expected in 7 days
Fair Value
Day's Range
1.0711.110
52 wk Range
0.8081.900
Key Statistics
Edit
Prev. Close
1.09
Open
1.11
Day's Range
1.071-1.11
52 wk Range
0.808-1.9
Volume
14.28K
Average Vol. (3m)
130.05K
1-Year Change
-22.7%
Book Value / Share
-0.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OKYO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.000
Upside
+553.59%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
Show more

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease; in phase 1 clinical trial for the treatment of neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201, which is in preclinical trial for the treatment of dry eye disease and neuropathic chronic pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Employees
3

Compare OKYO to Peers and Sector

Metrics to compare
OKYO
Peers
Sector
Relationship
P/E Ratio
−3.4x−9.8x−0.7x
PEG Ratio
−0.07−0.140.00
Price / Book
−5.1x1.9x2.6x
Price / LTM Sales
-22.9x3.1x
Upside (Analyst Target)
-130.5%49.4%
Fair Value Upside
Unlock22.4%8.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.000
(+553.59% Upside)

Earnings

Latest Release
Nov 29, 2024
EPS / Forecast
-0.08 / -0.09
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

1.870
MDXH
+1.08%
2.120
GMGI
+14.59%
13.18
BCAX
+0.69%
1.465
PMVP
+6.93%

FAQ

What Is the OKYO Pharma Ltd (OKYO) Stock Price Today?

The OKYO Pharma Ltd stock price today is 1.071

What Stock Exchange Does OKYO Pharma Ltd Trade On?

OKYO Pharma Ltd is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for OKYO Pharma Ltd?

The stock symbol for OKYO Pharma Ltd is "OKYO."

What Is the OKYO Pharma Ltd Market Cap?

As of today, OKYO Pharma Ltd market cap is 36.35M.

What is OKYO Pharma Ltd Earnings Per Share?

The OKYO Pharma Ltd EPS is -0.321.

What Is the Next OKYO Pharma Ltd Earnings Date?

OKYO Pharma Ltd will release its next earnings report on Feb 26, 2025.

From a Technical Analysis Perspective, Is OKYO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.